XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Restructuring Activities
6 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Restructuring Activities

NOTE D – RESTRUCTURING ACTIVITIES

 

Fiscal 2023 Life Sciences restructuring program

During December 2022, Ashland implemented a restructuring program within the Nutraceuticals business of the Life Sciences segment. Ashland recorded severance expense of zero and $1 million during the three and six months ended March 31, 2023. As of March 31, 2023, the severance reserve associated with this program was less than $1 million.